English
Insider transactions
EDGARScribe Therapeutics, Inc.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-18.
- Open-market purchases (code P)
- 9 transactions, 4,730,237 shares
- Sum of shares × price per share: 71,344,746.25
- Open-market sales (code S)
- 0 transactions, — shares
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–35 of 35
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-28 Filed 2026-07-28 | Aghazadeh Behzad Director · 10% owner · Other: See RemarksAvoro Capital Advisors LLC Director · 10% owner · Other: See RemarksAvoro Ventures LLC Director · Other: See Remarks | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 7,905 | 18.25 | 144,266.25Derived: shares × price per share. Exact value 144266.25. | 3,088,888 | Indirect (I) See footnotes | No | F2, F3, F6, F4, F5
| Open filing 0000902664-26-003270 Read from the filing’s XML Dispute this row |
| 2026-07-27 Filed 2026-07-29 | AH Bio Fund II, L.P. 10% ownerAH Equity Partners Bio II, L.L.C. 10% ownerAH Bio Fund III, L.P. 10% ownerAH Equity Partners Bio III, L.L.C. 10% ownerAndreessen Marc L 10% ownerHOROWITZ BENJAMIN A 10% owner | CConversion of derivative security | Acquired (A) | 2,051,742 | — | — | 2,051,742 | Indirect (I) By AH Bio Fund II, L.P. | No | F1, F2
| Open filing 0001231919-26-000813 Read from the filing’s XML Dispute this row |
| 2026-07-27 Filed 2026-07-29 | AH Bio Fund II, L.P. 10% ownerAH Equity Partners Bio II, L.L.C. 10% ownerAH Bio Fund III, L.P. 10% ownerAH Equity Partners Bio III, L.L.C. 10% ownerAndreessen Marc L 10% ownerHOROWITZ BENJAMIN A 10% owner | CConversion of derivative security | Acquired (A) | 697,650 | — | — | 697,650 | Indirect (I) By AH Bio Fund III, L.P. | No | F1, F3, F4
| Open filing 0001231919-26-000813 Read from the filing’s XML Dispute this row |
| 2026-07-27 Filed 2026-07-29 | AH Bio Fund II, L.P. 10% ownerAH Equity Partners Bio II, L.L.C. 10% ownerAH Bio Fund III, L.P. 10% ownerAH Equity Partners Bio III, L.L.C. 10% ownerAndreessen Marc L 10% ownerHOROWITZ BENJAMIN A 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 333,333 | 15 | 4,999,995Derived: shares × price per share. Exact value 4999995. | 2,385,075 | Indirect (I) By AH Bio Fund II, L.P. | No | F2
| Open filing 0001231919-26-000813 Read from the filing’s XML Dispute this row |
| 2026-07-27 Filed 2026-07-29 | AH Bio Fund II, L.P. 10% ownerAH Equity Partners Bio II, L.L.C. 10% ownerAH Bio Fund III, L.P. 10% ownerAH Equity Partners Bio III, L.L.C. 10% ownerAndreessen Marc L 10% ownerHOROWITZ BENJAMIN A 10% owner | CConversion of derivative security | Disposed (D) | 12,150,003 | 0 | — | 0 | Indirect (I) By AH Bio Fund II, L.P. | No | F1, F2
| Open filing 0001231919-26-000813 Read from the filing’s XML Dispute this row |
| 2026-07-27 Filed 2026-07-29 | AH Bio Fund II, L.P. 10% ownerAH Equity Partners Bio II, L.L.C. 10% ownerAH Bio Fund III, L.P. 10% ownerAH Equity Partners Bio III, L.L.C. 10% ownerAndreessen Marc L 10% ownerHOROWITZ BENJAMIN A 10% owner | CConversion of derivative security | Disposed (D) | 4,131,344 | 0 | — | 0 | Indirect (I) By AH Bio Fund III, L.P. | No | F1, F3, F4
| Open filing 0001231919-26-000813 Read from the filing’s XML Dispute this row |
| 2026-07-27 Filed 2026-07-29 | ORBIMED ADVISORS LLC DirectorOrbiMed Capital GP VIII LLC Director | CConversion of derivative security | Acquired (A) | 348,825 | — | — | 348,825 | Indirect (I) See footnotes | No | F1, F3, F4
| Open filing 0000947871-26-000733 Read from the filing’s XML Dispute this row |
| 2026-07-27 Filed 2026-07-29 | ORBIMED ADVISORS LLC DirectorOrbiMed Capital GP VIII LLC Director | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 1,000,000 | 15 | 15,000,000Derived: shares × price per share. Exact value 15000000. | 1,348,825 | Indirect (I) See footnotes | No | F2, F3, F4
| Open filing 0000947871-26-000733 Read from the filing’s XML Dispute this row |
| 2026-07-27 Filed 2026-07-29 | ORBIMED ADVISORS LLC DirectorOrbiMed Capital GP VIII LLC Director | CConversion of derivative security | Disposed (D) | 2,065,672 | 0 | — | 0 | Indirect (I) See footnotes | No | F1, F3, F4
| Open filing 0000947871-26-000733 Read from the filing’s XML Dispute this row |
| 2026-07-27 Filed 2026-07-29 | GORDON CARL L Director | CConversion of derivative security | Acquired (A) | 348,825 | — | — | 348,825 | Indirect (I) See footnotes | No | F1, F3, F4
| Open filing 0000947871-26-000734 Read from the filing’s XML Dispute this row |
| 2026-07-27 Filed 2026-07-29 | GORDON CARL L Director | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 1,000,000 | 15 | 15,000,000Derived: shares × price per share. Exact value 15000000. | 1,348,825 | Indirect (I) See footnotes | No | F2, F3, F4
| Open filing 0000947871-26-000734 Read from the filing’s XML Dispute this row |
| 2026-07-27 Filed 2026-07-29 | GORDON CARL L Director | CConversion of derivative security | Disposed (D) | 2,065,672 | 0 | — | 0 | Indirect (I) See footnotes | No | F1, F3, F4
| Open filing 0000947871-26-000734 Read from the filing’s XML Dispute this row |
| 2026-07-27 Filed 2026-07-29 | Doudna Jennifer A 10% owner | CConversion of derivative security | Acquired (A) | 12,511 | — | — | 603,547 | Direct (D) | No | F1
| Open filing 0001739090-26-000010 Read from the filing’s XML Dispute this row |
| 2026-07-27 Filed 2026-07-29 | Doudna Jennifer A 10% owner | CConversion of derivative security | Disposed (D) | 74,088 | — | — | 0 | Direct (D) | No | F1
| Open filing 0001739090-26-000010 Read from the filing’s XML Dispute this row |
| 2026-07-24 Filed 2026-07-28 | Aghazadeh Behzad Director · 10% owner · Other: See RemarksAvoro Capital Advisors LLC Director · 10% owner · Other: See RemarksAvoro Ventures LLC Director · Other: See Remarks | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 2,333,333 | 15.00 | 34,999,995Derived: shares × price per share. Exact value 34999995.00. | 3,030,983 | Indirect (I) See footnotes | No | F1, F6, F4, F5
| Open filing 0000902664-26-003270 Read from the filing’s XML Dispute this row |
| 2026-07-24 Filed 2026-07-28 | Aghazadeh Behzad Director · 10% owner · Other: See RemarksAvoro Capital Advisors LLC Director · 10% owner · Other: See RemarksAvoro Ventures LLC Director · Other: See Remarks | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 50,000 | 22.31 | 1,115,500Derived: shares × price per share. Exact value 1115500.00. | 3,080,983 | Indirect (I) See footnotes | No | F2, F6, F4, F5
| Open filing 0000902664-26-003270 Read from the filing’s XML Dispute this row |
| 2026-07-23 Filed 2026-07-28 | Staahl Brett 10% owner | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 19,385 | 0 | — | 19,385 | Direct (D) | No | F3
| Open filing 0002147277-26-000003 Read from the filing’s XML Dispute this row |
| 2026-07-23 Filed 2026-07-28 | Staahl Brett 10% owner | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 19,385 | 0 | — | 19,385 | Direct (D) | No | F4
| Open filing 0002147277-26-000003 Read from the filing’s XML Dispute this row |
| 2026-07-23 Filed 2026-07-27 | Lucas Svetlana Officer: Chief Business Officer | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 3,000 | 15 | 45,000Derived: shares × price per share. Exact value 45000. | 3,000 | Indirect (I) By Spouse | No | — | Open filing 0001781292-26-000007 Read from the filing’s XML Dispute this row |
| 2026-07-23 Filed 2026-07-27 | Lucas Svetlana Officer: Chief Business Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 109,426 | 0 | — | 109,426 | Direct (D) | No | F3
| Open filing 0001781292-26-000007 Read from the filing’s XML Dispute this row |
| 2026-07-23 Filed 2026-07-27 | Lucas Svetlana Officer: Chief Business Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 109,426 | 0 | — | 109,426 | Direct (D) | No | F4
| Open filing 0001781292-26-000007 Read from the filing’s XML Dispute this row |
| 2026-07-23 Filed 2026-07-27 | Oakes Benjamin L. Director · Officer: President, CEO · Other: Chairman of the Board | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 264,784 | 0 | — | 264,784 | Direct (D) | No | F3
| Open filing 0002127814-26-000004 Read from the filing’s XML Dispute this row |
| 2026-07-23 Filed 2026-07-27 | Oakes Benjamin L. Director · Officer: President, CEO · Other: Chairman of the Board | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 429,599 | 0 | — | 429,599 | Direct (D) | No | F4
| Open filing 0002127814-26-000004 Read from the filing’s XML Dispute this row |
| 2026-07-23 Filed 2026-07-27 | Watson James Dean Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 14,725 | 0 | — | 14,725 | Direct (D) | No | F1
| Open filing 0002130384-26-000004 Read from the filing’s XML Dispute this row |
| 2026-07-23 Filed 2026-07-27 | Aghazadeh Behzad Director · Other: See RemarksAvoro Capital Advisors LLC Director · Other: See RemarksAvoro Ventures LLC Director · Other: See Remarks | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 14,725 | 0 | — | 14,725 | Direct (D) | No | F1, F2, F3
| Open filing 0000902664-26-003254 Read from the filing’s XML Dispute this row |
| 2026-07-23 Filed 2026-07-27 | Bleharski Joshua Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 14,725 | 0 | — | 14,725 | Direct (D) | No | F1
| Open filing 0002075052-26-000004 Read from the filing’s XML Dispute this row |
| 2026-07-23 Filed 2026-07-27 | GORDON CARL L Director | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 14,725 | 0 | — | 14,725 | Direct (D) | No | F1
| Open filing 0001282930-26-000004 Read from the filing’s XML Dispute this row |
| 2026-07-23 Filed 2026-07-27 | Parrot David Officer: Chief Financial Officer | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 1,333 | 15 | 19,995Derived: shares × price per share. Exact value 19995. | 1,333 | Indirect (I) By Spouse | No | — | Open filing 0002127908-26-000004 Read from the filing’s XML Dispute this row |
| 2026-07-23 Filed 2026-07-27 | Parrot David Officer: Chief Financial Officer | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 1,333 | 15 | 19,995Derived: shares × price per share. Exact value 19995. | 1,333 | Indirect (I) By Child | No | — | Open filing 0002127908-26-000004 Read from the filing’s XML Dispute this row |
| 2026-07-23 Filed 2026-07-27 | Parrot David Officer: Chief Financial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 109,426 | 0 | — | 109,426 | Direct (D) | No | F3
| Open filing 0002127908-26-000004 Read from the filing’s XML Dispute this row |
| 2026-07-23 Filed 2026-07-27 | Parrot David Officer: Chief Financial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 109,426 | 0 | — | 109,426 | Direct (D) | No | F4
| Open filing 0002127908-26-000004 Read from the filing’s XML Dispute this row |
| 2026-03-13 Filed 2026-07-28 | Staahl Brett 10% owner | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 4,755 | 0 | — | 4,755 | Direct (D) | No | F1, F2
| Open filing 0002147277-26-000003 Read from the filing’s XML Dispute this row |
| 2026-03-13 Filed 2026-07-27 | Lucas Svetlana Officer: Chief Business Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 9,547 | 0 | — | 9,547 | Direct (D) | No | F1, F2
| Open filing 0001781292-26-000007 Read from the filing’s XML Dispute this row |
| 2026-03-13 Filed 2026-07-27 | Oakes Benjamin L. Director · Officer: President, CEO · Other: Chairman of the Board | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 12,969 | 0 | — | 12,969 | Direct (D) | No | F1, F2
| Open filing 0002127814-26-000004 Read from the filing’s XML Dispute this row |
| 2026-03-13 Filed 2026-07-27 | Parrot David Officer: Chief Financial Officer | AGrant, award or other acquisition pursuant to Rule 16b-3(d) | Acquired (A) | 8,909 | 0 | — | 8,909 | Direct (D) | No | F1, F2
| Open filing 0002127908-26-000004 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 8,793 filings read, the latest filed 2026-11-17. Prior quarter ending 2026-06-30: 9,164 filings read.
Showing 1–50 of 62
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| a16z Capital Management, L.L.C. | 3,082,725 SH | 56,737,554 dollars | Not in the prior quarter’s filings read | Open filing 0001540358-26-000014 Filed 2026-11-16 Dispute this row |
| Avoro Capital Advisors LLC | 2,598,973 SH | 47,834,098 dollars | Not in the prior quarter’s filings read | Open filing 0001104659-26-127608 Filed 2026-11-16 Dispute this row |
| RA CAPITAL MANAGEMENT, L.P. | 1,802,178 SH | 33,169,086 dollars | Not in the prior quarter’s filings read | Open filing 0001104659-26-128411 Filed 2026-11-16 Dispute this row |
| ORBIMED ADVISORS LLC | 1,348,825 SH | 24,825,124 dollars | Not in the prior quarter’s filings read | Open filing 0001172661-26-005349 Filed 2026-11-16 Dispute this row |
| PERCEPTIVE ADVISORS LLC | 920,341 SH | 16,938,876 dollars | Not in the prior quarter’s filings read | Open filing 0001012975-26-001063 Filed 2026-11-16 Dispute this row |
| ARK Investment Management LLC | 786,921 SH | 14,483,278 dollars | Not in the prior quarter’s filings read | Open filing 0001104659-26-126785 Filed 2026-11-13 Dispute this row |
| BAKER BROS. ADVISORS LP | 688,691 SH | 12,675,358 dollars | Not in the prior quarter’s filings read | Open filing 0001104659-26-128308 Filed 2026-11-16 Dispute this row |
| PRICE T ROWE ASSOCIATES INC /MD/ Partly reported under another manager | 684,706 SH | 12,603 dollars | Not in the prior quarter’s filings read | Open filing 0000080255-26-000736 Filed 2026-11-16 Dispute this row |
| BlackRock, Inc. Partly reported under another manager | 679,786 SH | 12,511,461 dollars | Not in the prior quarter’s filings read | Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row |
| Sanofi | 500,000 SH | 9,202,500 dollars | Not in the prior quarter’s filings read | Open filing 0001193125-26-448717 Filed 2026-11-05 Dispute this row |
| VANGUARD CAPITAL MANAGEMENT LLC | 407,630 SH | 7,502,430 dollars | Not in the prior quarter’s filings read | Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row |
| FRANKLIN TEMPLETON INC Partly reported under another manager | 380,019 SH | 6,376,719 dollars | Not in the prior quarter’s filings read | Open filing 0000038777-26-000291 Filed 2026-11-12 Dispute this row |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 380,000 SH | 6,993,900 dollars | Not in the prior quarter’s filings read | Open filing 0001172661-26-005200 Filed 2026-11-16 Dispute this row |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 380,000 SH | 6,993,900 dollars | Not in the prior quarter’s filings read | Open filing 0000908834-26-000540 Filed 2026-11-16 Dispute this row |
| GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager | 245,412 SH | 4,518,022 dollars | Not in the prior quarter’s filings read | Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row |
| STATE STREET CORP Partly reported under another manager | 171,147 SH | 3,149,961 dollars | Not in the prior quarter’s filings read | Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row |
| Alyeska Investment Group, L.P. | 150,000 SH | 2,760,750 dollars | Not in the prior quarter’s filings read | Open filing 0001172661-26-005329 Filed 2026-11-16 Dispute this row |
| Menlo Ventures Management, L.P. | 97,690 SH | 1,797,984 dollars | Not in the prior quarter’s filings read | Open filing 0001911541-26-000014 Filed 2026-11-06 Dispute this row |
| TD ASSET MANAGEMENT INC | 83,342 SH | 1,919,366 dollars | Not in the prior quarter’s filings read | Open filing 0001193125-26-460060 Filed 2026-11-13 Dispute this row |
| Amova Asset Management Americas, Inc. Partly reported under another manager | 74,910 SH | 1,378,344 dollars | Not in the prior quarter’s filings read | Open filing 0001140361-26-043552 Filed 2026-11-13 Dispute this row |
| Sumitomo Mitsui Trust Group, Inc. Partly reported under another manager | 74,910 SH | 1,378,719 dollars | Not in the prior quarter’s filings read | Open filing 0001214659-26-013361 Filed 2026-10-29 Dispute this row |
| NORTHERN TRUST CORP Partly reported under another manager | 74,721 SH | 1,375,240 dollars | Not in the prior quarter’s filings read | Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row |
| UBS Group AG Partly reported under another manager | 71,067 SH | 1,307,988 dollars | Not in the prior quarter’s filings read | Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 67,039 SH | 1,233,853 dollars | Not in the prior quarter’s filings read | Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row |
| VANGUARD FIDUCIARY TRUST CO | 64,267 SH | 1,182,834 dollars | Not in the prior quarter’s filings read | Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row |
| Nuveen, LLC Partly reported under another manager | 41,470 SH | 763,255 dollars | Not in the prior quarter’s filings read | Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 40,876 SH | 0 dollars | Not in the prior quarter’s filings read | Open filing 0001213900-26-119414 Filed 2026-11-13 Dispute this row |
| Longaeva Partners L.P. Partly reported under another manager | 34,034 SH | 626,396 dollars | Not in the prior quarter’s filings read | Open filing 0001193125-26-463222 Filed 2026-11-16 Dispute this row |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31,644 SH | 582,408 dollars | Not in the prior quarter’s filings read | Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row |
| BANK OF AMERICA CORP /DE/ Partly reported under another manager | 27,589 SH | 507,776 dollars | Not in the prior quarter’s filings read | Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row |
| Point72 Asset Management, L.P. | 22,771 SH | 419,100 dollars | Not in the prior quarter’s filings read | Open filing 0000919574-26-008126 Filed 2026-11-16 Dispute this row |
| WELLS FARGO COMPANY/MN Partly reported under another manager | 22,500 SH | 414,112 dollars | Not in the prior quarter’s filings read | Open filing 0000072971-26-000342 Filed 2026-11-16 Dispute this row |
| GOLDMAN SACHS GROUP INC Partly reported under another manager | 21,635 SH | 398,192 dollars | Not in the prior quarter’s filings read | Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row |
| Bank of New York Mellon Corp Partly reported under another manager | 20,396 SH | 375,389 dollars | Not in the prior quarter’s filings read | Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row |
| Focus Partners Wealth | 20,025 SH | 368,560 dollars | Not in the prior quarter’s filings read | Open filing 0001542153-26-000021 Filed 2026-11-12 Dispute this row |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP Partly reported under another manager | 13,641 SH | 251,063 dollars | Not in the prior quarter’s filings read | Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row |
| SEVEN GRAND MANAGERS, LLC | 10,000 SH | 184,050 dollars | Not in the prior quarter’s filings read | Open filing 0001420506-26-002775 Filed 2026-11-16 Dispute this row |
| RHUMBLINE ADVISERS | 8,897 SH | 163,742 dollars | Not in the prior quarter’s filings read | Open filing 0001115418-26-000015 Filed 2026-11-10 Dispute this row |
| MORGAN STANLEY Partly reported under another manager | 8,536 SH | 157,106 dollars | Not in the prior quarter’s filings read | Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row |
| DEUTSCHE BANK AG\ Partly reported under another manager | 8,269 SH | 152,233 dollars | Not in the prior quarter’s filings read | Open filing 0000948046-26-000083 Filed 2026-11-06 Dispute this row |
| JPMORGAN CHASE CO Partly reported under another manager | 6,028 SH | 138,825 dollars | Not in the prior quarter’s filings read | Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row |
| MetLife Investment Management, LLC Partly reported under another manager | 5,814 SH | 107,007 dollars | Not in the prior quarter’s filings read | Open filing 0001628280-26-073956 Filed 2026-11-16 Dispute this row |
| CITIGROUP INC Partly reported under another manager | 4,742 SH | 87,277 dollars | Not in the prior quarter’s filings read | Open filing 0000831001-26-000052 Filed 2026-11-04 Dispute this row |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Partly reported under another manager | 4,636 SH | 85,326 dollars | Not in the prior quarter’s filings read | Open filing 0000905148-26-004850 Filed 2026-11-16 Dispute this row |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 4,195 SH | 77,209 dollars | Not in the prior quarter’s filings read | Open filing 0001398344-26-020056 Filed 2026-11-13 Dispute this row |
| Vanguard Global Advisers, LLC | 3,592 SH | 66,111 dollars | Not in the prior quarter’s filings read | Open filing 0001811242-26-000017 Filed 2026-11-13 Dispute this row |
| TEMA ETFS LLC | 3,046 SH | 56,062 dollars | Not in the prior quarter’s filings read | Open filing 0001829126-26-011223 Filed 2026-10-16 Dispute this row |
| STRS OHIO | 2,600 SH | 47,853 dollars | Not in the prior quarter’s filings read | Open filing 0000820478-26-000018 Filed 2026-10-30 Dispute this row |
| BNP PARIBAS FINANCIAL MARKETS Partly reported under another manager | 2,400 SH | 44,172 dollars | Not in the prior quarter’s filings read | Open filing 0001166588-26-000012 Filed 2026-11-12 Dispute this row |
| Police Firemen's Retirement System of New Jersey Partly reported under another manager | 2,289 SH | 42,129 dollars | Not in the prior quarter’s filings read | Open filing 0002040686-26-000007 Filed 2026-11-09 Dispute this row |
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| AH Bio Fund II, L.P. Common Stock, $0.001 par value per share | 12.6 | 2,385,075.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G | Open filing 0001725721-26-000009 Dispute this row |
| AH Equity Partners Bio II, L.L.C. Common Stock, $0.001 par value per share | 12.6 | 2,385,075.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G | Open filing 0001725721-26-000009 Dispute this row |
| AH Bio Fund III, L.P. Common Stock, $0.001 par value per share | 3.7 | 697,650.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G | Open filing 0001725721-26-000009 Dispute this row |
| AH Equity Partners Bio III, L.L.C. Common Stock, $0.001 par value per share | 3.7 | 697,650.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G | Open filing 0001725721-26-000009 Dispute this row |
| Marc L. Andreessen Common Stock, $0.001 par value per share | 16.3 | 3,082,725.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G | Open filing 0001725721-26-000009 Dispute this row |
| Benjamin A. Horowitz Common Stock, $0.001 par value per share | 16.3 | 3,082,725.00 | 09/30/2026 Filed 2026-11-16 | SCHEDULE 13G | Open filing 0001725721-26-000009 Dispute this row |
| RA Capital Management, L.P. Common Stock, $0.001 par value per share | 9.6 | 1,802,178.00 | 07/27/2026 Filed 2026-08-03 | SCHEDULE 13G | Open filing 0001346824-26-000210 Dispute this row |
| Peter Kolchinsky Common Stock, $0.001 par value per share | 9.6 | 1,802,178.00 | 07/27/2026 Filed 2026-08-03 | SCHEDULE 13G | Open filing 0001346824-26-000210 Dispute this row |
| Rajeev Shah Common Stock, $0.001 par value per share | 9.6 | 1,802,178.00 | 07/27/2026 Filed 2026-08-03 | SCHEDULE 13G | Open filing 0001346824-26-000210 Dispute this row |
| RA Capital Healthcare Fund, L.P. Common Stock, $0.001 par value per share | 9.1 | 1,714,582.00 | 07/27/2026 Filed 2026-08-03 | SCHEDULE 13G | Open filing 0001346824-26-000210 Dispute this row |
| ORBIMED ADVISORS LLC Common Stock | 7.2 | 1,348,825.00 | 07/27/2026 Filed 2026-07-29 | SCHEDULE 13D | Open filing 0000947871-26-000732 Dispute this row |
| ORBIMED CAPITAL GP VIII LLC Common Stock | 7.2 | 1,348,825.00 | 07/27/2026 Filed 2026-07-29 | SCHEDULE 13D | Open filing 0000947871-26-000732 Dispute this row |
| Avoro Capital Advisors LLC Common Stock, $0.001 par value per share | 13.78 | 2,598,973.00 | 07/24/2026 Filed 2026-07-30 | SCHEDULE 13D | Open filing 0000902664-26-003281 Dispute this row |
| Avoro Ventures LLC Common Stock, $0.001 par value per share | 2.60 | 489,915.00 | 07/24/2026 Filed 2026-07-30 | SCHEDULE 13D | Open filing 0000902664-26-003281 Dispute this row |
| Aghazadeh Behzad Common Stock, $0.001 par value per share | 16.37 | 3,088,888.00 | 07/24/2026 Filed 2026-07-30 | SCHEDULE 13D | Open filing 0000902664-26-003281 Dispute this row |
| ELI LILLY Co Common stock, $0.001 par value per share | 7.3 | 1,388,161.00 | 07/23/2026 Filed 2026-07-30 | SCHEDULE 13D | Open filing 0000059478-26-000072 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,241,208 filings read, dated 2004-06-14 to 2026-11-17: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 1 |
| 2016 | 204,322 |
| 2017 | 202,494 |
| 2018 | 202,048 |
| 2019 | 193,638 |
| 2020 | 144,184 |
| 2021 | 224,474 |
| 2022 | 158,941 |
| 2023 | 199,811 |
| 2024 | 209,823 |
| 2025 | 235,520 |
| 2026 | 260,174 |
Filings made before the SEC required XML are listed, not extracted.